Study on Clinical Features, Treatment Mode and Survival of Sarcoma

To Evaluate the Efficacy and Feasibility of Modified Reduce-volume Target IMRT in the Treatment of Patients With Non-metastatic NPC

NCT04387266 ·Status: COMPLETED

Combining RT With Immunotherapy and Chemotherapy in Metastatic Nasopharyngeal Carcinoma

NCT05385926 ·Status: RECRUITING ·Phase: PHASE2

To Study the Feasibility and Quality of Life of Medial Group Retropharyngeal Node Sparing in Nasopharyngeal Carcinoma

NCT03346109 ·Status: UNKNOWN ·Phase: NA

Hypoxia Imaging -Guided Radiotherapy of Nasopharyngeal Carcinoma

NCT02089204 ·Status: UNKNOWN

Concurrent Chemotherapy for Recurrent T3/T4 Nasopharyngeal Carcinoma

NCT04136886 ·Status: RECRUITING ·Phase: PHASE3

Study of Chemoradiotherapy Combined With Cetuximab in Nasopharyngeal Carcinoma

NCT01271439 ·Status: COMPLETED ·Phase: PHASE2

The Role of Adding Concurrent Chemotherapy to IMRT in the Treatment of Stage II Nasopharyngeal Carcinoma

NCT02116231 ·Status: UNKNOWN ·Phase: PHASE2

A Real-world Study of the Efficacy and Safety of PD-1 Inhibitors Combined With Chemoradiotherapy in Lung Metastatic Nasopharyngeal Carcinoma

NCT07062484 ·Status: NOT_YET_RECRUITING ·Phase: NA

Chemotherapy Combined With Immunotherapy in HER 2 Insertion or Amplification Advanced NSCLC

NCT04324125 ·Status: RECRUITING

Atezolizumab Plus Bevacizumab and Chemotherapy in First-Line Metastatic Nonsquamous NSCLC

NCT05261438 ·Status: COMPLETED

GP-induced Chemotherapy Combined With IMRT and TPF-induced Chemotherapy Combined With IMRT in the Treatment of Distant Metastatic Nasopharyngeal Carcinoma

NCT03723343 ·Status: UNKNOWN

Safety and Efficacy Evaluation of 4th Generation Safety-engineered CAR T Cells Targeting Sarcomas

NCT03356782 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Concurrent Chemotherapy for the Intermediate Risk Nasopharyngeal Carcinoma In Intensity-modulated Radiotherapy Era

NCT02633202 ·Status: COMPLETED ·Phase: PHASE3

Radiotherapy Combined With PD-1 Inhibitors and Chemotherapy in the Treatment of NSCLC Patients With Symptomatic Brain Metastases

NCT05638425 ·Status: RECRUITING

The Efficacy and Safety of De-escalated Postoperative Radiotherapy in Locally Advanced HNSCC With pCR/MPR

NCT05854823 ·Status: RECRUITING ·Phase: NA

SBRT Combined With PD-1 Antibody and Chemotherapy in Oligometastatic Nasopharyngeal Carcinoma

NCT05524168 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Low-dose Radiotherapy and Neoadjuvant Chemotherapy Sequential Concurrent Chemoradiotherapy for Locally Advanced Nasopharyngeal Carcinoma

NCT05503914 ·Status: UNKNOWN ·Phase: NA

Endoscopic Surgery vs. Intensity Modulated Radiotherapy for Stage I Nasopharyngeal Carcinoma.

NCT06533267 ·Status: RECRUITING ·Phase: NA

Study of Concurrent Chemotherapy and Radiotherapy for Stage II Nasopharyngeal Carcinoma

NCT00817258 ·Status: UNKNOWN ·Phase: PHASE2

Tislelizumab Combined With SBRT for the Treatment of Head and Neck Squamous Cell Carcinoma

NCT06673693 ·Status: RECRUITING ·Phase: PHASE2

A Clinical Trial Comparing Low-Dose RT + Targeted Therapy+ Immunotherapy vs Targeted Therapy+ Immunotherapy Alone as Neoadjuvant Therapy in Operable HNSCC Patients.

NCT07040956 ·Status: RECRUITING ·Phase: PHASE2

TPExtreme Induced Chemotherapy Followed by Surgery and Radiotherapy in the Oral Carcinoma.

NCT05872880 ·Status: RECRUITING

A Study of Nasopharyngeal Carcinoma From Guangdong

NCT03003182 ·Status: UNKNOWN

Split-course Hypofractionated Radiotherapy With Concurrent Chemotherapy in Locally Advanced Non-small Cell Lung Cancer

NCT04212052 ·Status: COMPLETED ·Phase: PHASE2

Neoadjuvant and Adjuvant Tislelizumab for Nasopharyngeal Carcinoma

NCT05211232 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3